Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins - Top-Institutions - MDSpire

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

  • By

  • Vikrama Raja

  • Carlos Aguiar

  • Nasreen Alsayed

  • Yogeyaa S. Chibber

  • Hussein ElBadawi

  • Michel Farnier

  • Kumari Pushpa

  • Lale Tokgözoglu

  • Alberto Zambon

  • Jean-Pascal Berrou

  • Michel P. Hermans

  • June 4, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

  • #2

    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital
    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

    New York, New York

    Key Differentiators

    • Cardiology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Cardiology

  • #4

    Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of Medicine

    Chicago, Illinois

    Key Differentiators

    • Cardiology

  • #5

    Tufts University
    Tufts University

    Medford, Massachusetts

    Key Differentiators

    • Cardiology

Original Source(s)

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

  • by Vikrama Raja, Carlos Aguiar, Nasreen Alsayed, Yogeyaa S. Chibber, Hussein ElBadawi, Michel Farnier, Kumari Pushpa, Lale Tokgözoglu, Alberto Zambon, Jean-Pascal Berrou, Michel P. Hermans

  • June 4, 2026

Related Content

Vitamin D: The Answer May Be Genetic

A post hoc D2d analysis found vitamin D3 supplementation was linked to lower diabetes risk only among patients with ApaI AC or CC genotypes.

Grip Strength And Waist Size Linked to Diabetes

Researchers found that patients with higher waist circumference and lower grip strength had the greatest risk for developing type 2 diabetes during long-term follow-up.

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II